Renalytix Book Value Per Share vs. Market Capitalization

RNLX Stock  USD 0.41  0.05  13.89%   
Based on the key profitability measurements obtained from Renalytix's financial statements, Renalytix AI may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in July. Profitability indicators assess Renalytix's ability to earn profits and add value for shareholders.
 
Book Value Per Share  
First Reported
2010-12-31
Previous Quarter
0.52
Current Value
0.49
Quarterly Volatility
0.52028874
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Renalytix's Days Sales Outstanding is fairly stable compared to the past year. Days Of Sales Outstanding is likely to rise to 178.93 in 2024, whereas Price To Sales Ratio is likely to drop 38.53 in 2024. Change To Netincome is likely to rise to about 5.7 M in 2024, despite the fact that Accumulated Other Comprehensive Income is likely to grow to (1.2 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.360.24
Way Up
Slightly volatile
For Renalytix profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Renalytix to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Renalytix AI utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Renalytix's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Renalytix AI over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Renalytix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renalytix. If investors know Renalytix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renalytix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.76)
Revenue Per Share
0.046
Quarterly Revenue Growth
(0.26)
Return On Assets
(0.86)
Return On Equity
(10.73)
The market value of Renalytix AI is measured differently than its book value, which is the value of Renalytix that is recorded on the company's balance sheet. Investors also form their own opinion of Renalytix's value that differs from its market value or its book value, called intrinsic value, which is Renalytix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renalytix's market value can be influenced by many factors that don't directly affect Renalytix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renalytix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Renalytix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renalytix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Renalytix AI Market Capitalization vs. Book Value Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Renalytix's current stock value. Our valuation model uses many indicators to compare Renalytix value to that of its competitors to determine the firm's financial worth.
Renalytix AI is rated below average in book value per share category among related companies. It is rated fifth in market capitalization category among related companies . At this time, Renalytix's Book Value Per Share is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Renalytix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Renalytix's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Renalytix's earnings, one of the primary drivers of an investment's value.

Renalytix Market Capitalization vs. Book Value Per Share

Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Renalytix

Book Value per Share

 = 

Common Equity

Average Shares

 = 
(0.09) X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Renalytix

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
34.3 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Renalytix Market Capitalization vs Competition

Renalytix AI is rated fifth in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 8.8 Billion. Renalytix adds roughly 34.3 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Revenue  Valuation  Workforce  Total debt

Renalytix Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Renalytix, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Renalytix will eventually generate negative long term returns. The profitability progress is the general direction of Renalytix's change in net profit over the period of time. It can combine multiple indicators of Renalytix, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-1.3 M-1.2 M
Net Loss-41 M-39 M
Net Interest Income585.4 K556.1 K
Interest Income585.4 K556.1 K
Operating Income-38.1 M-40 M
Net Loss-41.6 M-43.7 M
Income Before Tax-41.6 M-43.7 M
Total Other Income Expense Net-3.9 M-3.7 M
Net Loss-41.6 M-39.5 M
Income Tax Expense2.3 KK
Change To Netincome4.7 M5.7 M
Net Loss(1.29)(1.36)
Income Quality 0.64  0.62 
Net Income Per E B T 0.90  0.76 

Renalytix Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Renalytix. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Renalytix position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Renalytix's important profitability drivers and their relationship over time.

Use Renalytix in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Renalytix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Renalytix will appreciate offsetting losses from the drop in the long position's value.

Renalytix Pair Trading

Renalytix AI Pair Trading Analysis

The ability to find closely correlated positions to Renalytix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Renalytix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Renalytix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Renalytix AI to buy it.
The correlation of Renalytix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Renalytix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Renalytix AI moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Renalytix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Renalytix position

In addition to having Renalytix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Casinos Thematic Idea Now

Casinos
Casinos Theme
Companies that are related to providing casino-type services across multiple geographical areas. The Casinos theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Casinos Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Renalytix AI offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Renalytix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Renalytix Ai Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Renalytix Ai Stock:
Check out Your Equity Center.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Renalytix Stock analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
To fully project Renalytix's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Renalytix AI at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Renalytix's income statement, its balance sheet, and the statement of cash flows.
Potential Renalytix investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Renalytix investors may work on each financial statement separately, they are all related. The changes in Renalytix's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Renalytix's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.